| 000 | 01826 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516172541.0 | ||
| 264 | 0 | _c20140722 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.1408 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorodovsky, Alexandra | |
| 245 | 0 | 0 |
_a5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. _h[electronic resource] |
| 260 |
_bOncotarget _cOct 2013 |
||
| 300 |
_a1737-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xpharmacology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA Methylation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aIsocitrate Dehydrogenase _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aSalmasi, Vafi | |
| 700 | 1 | _aTurcan, Sevin | |
| 700 | 1 | _aFabius, Armida W M | |
| 700 | 1 | _aBaia, Gilson S | |
| 700 | 1 | _aEberhart, Charles G | |
| 700 | 1 | _aWeingart, Jon D | |
| 700 | 1 | _aGallia, Gary L | |
| 700 | 1 | _aBaylin, Stephen B | |
| 700 | 1 | _aChan, Timothy A | |
| 700 | 1 | _aRiggins, Gregory J | |
| 773 | 0 |
_tOncotarget _gvol. 4 _gno. 10 _gp. 1737-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.1408 _zAvailable from publisher's website |
| 999 |
_c23127621 _d23127621 |
||